A prospective study that analyzed the use of cannabis treatment in the elderly, measuring for pain intensity, quality of life, and adverse effects at six months follow-up. The most common indications for cannabis treatment were pain (66.6%) and cancer (60.8%). The study found that the therapeutic use of cannabis is safe and efficacious in the elderly population.

KEY RESULTS:

• Reported pain significantly reduced from a median of 8/10 to 4/10
  
• Prior to treatment, 66.8% of patients reported high pain-intensity; at six months, this number decreased to only 7.6% of patients
  
• 93.7% of patients reported that the cannabis treatment improved their condition
  
• 35.1% of patients reported a decrease in the number of drugs taken or the dosage
  
• 18.1% of patients stopped using opioid analgesics or reduced their dose
  
• The most common reported side effects were dizziness (9.7%) and dry mouth (7.1%) 

STRAINS:

Alaska, Erez, Avidekel, and other CBD-rich Tikun Olam strains (Raphael, Metatron, Michael)

STUDY POPULATION:
2736 patients aged 65+; at 6 months, 901 patients were eligible for follow-up and completed the survey